R&F Capital Advisors’s Aceragen Inc ACGN Stock Holding History

R&F Capital Advisors’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$49K	Sell	145 -26	-15%	-$6.27K	0.01%	649
2016 Q4	$35K	Buy	+171	New	+$40.8K	0.01%	478

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

R&F Capital Advisors's ACGN Position: Q1 2017 in Review

R&F Capital Advisors reduced its Aceragen Inc (ACGN) stake by 15% in Q1 2017, selling an estimated $6.27K and leaving 145 shares worth $49K. The position accounts for 0.01% of the portfolio, ranked #649.

R&F Capital Advisors first reported a position in ACGN in Q4 2016 and has held it in 2 quarters since. 82 funds tracked by Wall St. Rank hold ACGN as of Q1 2017.

R&F Capital Advisors held 145 shares of Aceragen Inc worth $49K as of Q1 2017.
R&F Capital Advisors sold 26 Aceragen Inc shares in Q1 2017, an estimated $6.27K.
Aceragen Inc made up 0.01% of R&F Capital Advisors's portfolio in Q1 2017, its #649 holding.
R&F Capital Advisors first reported a position in Aceragen Inc in Q4 2016 and has held it in 2 quarters since.
82 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.